NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I already said previously that Bosch here is referring to NWBOs other now halted DCVAXL past phase 2 trials of many years ago. While these phase 2 trials were ongoing they were given the RA right to offer compassionate use for these other indications. NWBO left those trials by RA regulation the sponsor then also no longer has the right to SELL compassionate use for the cancer indications the sponsor halted the trial of.

Thermo's brother has been treated with DCVAXL for another indication than GBM years ago, while the DCVAXL phase 2 trials were ongoing.

Therefore the conclusion that NWBO NO LONGER has the RIGHT to sell DCVAXL for other indications than (r/n) GBM is CORRECT. That's common Biotech FDA/EMA/MHRA aka RA knowledge.

Also is it equally INcorrect that even IF NWBO would not have left/halted the Phase 2 trials for other DCVAXL trials they do NOT have the right to SELL compassionate use for other indications they are not running a trial for.